跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
首页
药物
recombinant human surfactant protein
recombinant human surfactant protein
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS FOR TREATING PREMATURE NEWBORN INFANTS BY ADMINISTRATION OF RECOMBINANT HUMAN SURFACTANT PROTEIN D (RHSP-D)
申请人: AIRWAY THERAPEUTICS INC
优先权: 2023
EP
US
WO
3 件公开
Recombinant human glaze matrix protein preparation method based on double salting-out and surfactant denaturation and renaturation
申请人: GUANGZHOU ARAHELIO BIOLOGICAL TECH CO LTD
优先权: 2025
CN
METHODS AND COMPOSITIONS COMPRISING SURFACTANT PROTEIN D (SP-D)
申请人: AIRWAY THERAPEUTICS INC
优先权: 2018
CN
EP
US
WO
5 件公开
METHOD FOR TREATING INFECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
申请人: WANG JIU YAO
优先权: 2022
US
Surfactant protein D for the treatment of disorders associated with lung injury
申请人: WHITSETT JEFFREY A
优先权: 2011
US
4 件公开
RECOMBINANT ADENOVIRUS VECTOR VACCINE FORMULATION AND PREPARATION METHOD THEREFOR
申请人: CANSINO BIOLOGICS INC
优先权: 2024
CN
WO
2 件公开
USE OF SURFACTANT PROTEIN D TO TREAT VIRAL INFECTIONS
申请人: AIRWAY THERAPEUTICS INC
优先权: 2020
EP
RECOMBINANT HEGF-CRM197 TUMOR THERAPEUTIC VACCINE FORMULATION
申请人: SHANGHAI HUIMMUTECH BIOTECHNOLOGY CO LTD
优先权: 2021
US
药物
反馈
